Age as a determinant of transcranial magnetic stimulation efficacy for major depressive disorder in a naturalistic clinic setting

Age as a determinant of transcranial magnetic stimulation efficacy for major depressive disorder in a naturalistic clinic setting
Major depressive disorder (MDD) is a highly prevalent, debilitating public health issue that is a leading cause of disease burden throughout the world [1]. Pharmacotherapy is typically used as a first line treatment for MDD [2]. Treatment resistant depression (TRD) is commonly defined as failure to respond or achieve remission after two or more trials of antidepressant medication of adequate dose and duration. Each year, 30.9% of adults develop TRD [3] (see ). ... read more
Brain Stimulation Journal FeedBy Phillip Goldman, Emily Pedersen, Maximilian Bailey, Max Hasse, Martha Koo